Phathom Pharmaceuticals, Inc. Annual Operating Lease, Payments in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Phathom Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2020 to 2023.
  • Phathom Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $200K, unchanged year-over-year.
  • Phathom Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $1.1M, unchanged from 2022.
  • Phathom Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $1.1M, a 57.1% increase from 2021.
  • Phathom Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $700K, a 22.2% decline from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.1M $0 0% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-06-14
2022 $1.1M +$400K +57.1% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-06-14
2021 $700K -$200K -22.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $900K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.